MedPath
HSA Approval

GELOFUSINE INFUSION

SIN08166P

GELOFUSINE INFUSION

GELOFUSINE INFUSION

May 12, 1995

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA31

electrolytes in combination with other drugs

Manufacturer Information

B. Braun Singapore Pte Ltd.

B.Braun Medical Industries

Active Ingredients

SUCCINYLATED GELATIN (MODIFIED FLUID GELATIN)

40 g/1000 ml

Succinylated gelatin

SODIUM CHLORIDE

7.01 g/1000 ml

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GELOFUSINE INFUSION - HSA Approval | MedPath